Navigation Links
ProMetic to present at Merriman Curhan Ford's Investor Summit 2008 on September 16th
Date:9/12/2008

Hundreds of Institutional Investors to Attend Conference

MONTREAL, Sept. 12 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic"), today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will present at Merriman Curhan Ford's 5th annual Investor Summit on September 16, 2008 at 16:00 (PDT). This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco.

More information about the conference can be found at: http://www.mcfco.com.

About Merriman Curhan Ford

Merriman Curhan Ford (NASDAQ:MERR) is a financial services firm focused on fast-growing companies and the institutions who invest in them. The company offers high-quality investment banking, equity research, institutional services, primary market research, asset management and corporate & venture services, and specializes in four growth industry sectors: CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. For more information, please go to http://www.mcfco.com.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (http://www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the U.S., Europe, Asia and in the Middle-East.


'/>"/>
SOURCE Prometic Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
2. ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference
3. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
4. Prometic provides information for its Annual and Special Meeting of Shareholders
5. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
6. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
7. Prometic to present at the American Chemical Society
8. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
9. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
10. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
11. ProMetic provides business update - Over $35 million worth of business secured in January
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... ... digital pathology, today announced their digital pathology technology has the potential to eliminate ... five medical centers in The Netherlands as part of the 2017 ISBI ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... flow controllers based on capillary thermal mass flow technology provide exponentially more accurate ... applications. Over 80% of all industrial processes—such as those involving chemical reactions, ...
(Date:4/27/2017)... a distinguished resource for research, development and commercialization of ... Thomas C. Seoh as President and CEO. Mr. Seoh ... becomes Executive Chairman and will continue to serve as ... Thomas Seoh commented, "I am excited and honored ... firm,s remarkable team of life science professionals, all of ...
(Date:4/26/2017)... ... April 26, 2017 , ... Baltimore bio ... MailGuardtm mail security screening solution at the National Postal Forum 2017 in Baltimore, ... a fast, highly accurate, easy to use and low cost threat detection solution ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
Breaking Biology News(10 mins):